Products of the respiratory syncytial virus diagnostics market includes direct fluorescent antibody (DFA) method, rapid antigen diagnostic test (RADTs), molecular diagnostics, chromatographic immunoassay, diagnostic imaging, gel microdroplets, flow cytometry, and others.
North America dominates the market for respiratory syncytial virus diagnosis because of the rising incidence of these infections and the increasing number of babies. In addition, the medical system continues to evolve, and more and more government initiatives, China, India, Japan and Malaysia are expected to become the fastest growing markets in the region.
Market Analysis and Insights: Global Respiratory Syncytial Virus Diagnostics Market
The global Respiratory Syncytial Virus Diagnostics market size is projected to reach US$ 599.3 million by 2026, from US$ 564.4 million in 2020, at a CAGR of 5.7%% during 2021-2026.
Global Respiratory Syncytial Virus Diagnostics Scope and Market Size
Respiratory Syncytial Virus Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Respiratory Syncytial Virus Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Becton Dickinson
Abbott Laboratories
Abbott
Beckman Coulter/Danaher
Bio-Rad Laboratories
Coris BioConcept
DiaSorin SPA
Eiken Chemical
Elitech
Fujirebio
Grifols
Hoffmann La Roche
Hologic
Novartis Diagnostics
Ortho Clinical Diagnostics
Roche Diagnostics
Scienion
Respiratory Syncytial Virus Diagnostics Breakdown Data by Type
Direct Fluorescent Antibody Method
Rapid Antigen Diagnostic Tests
Molecular Diagnostics
Chromatographic Immunoassay
Diagnostic Imaging
Gel Microdroplets
Flow Cytometry
Other
Respiratory Syncytial Virus Diagnostics Breakdown Data by Application
Hospitals
Laboratory
Clinics
Homecare
North America dominates the market for respiratory syncytial virus diagnosis because of the rising incidence of these infections and the increasing number of babies. In addition, the medical system continues to evolve, and more and more government initiatives, China, India, Japan and Malaysia are expected to become the fastest growing markets in the region.
Market Analysis and Insights: Global Respiratory Syncytial Virus Diagnostics Market
The global Respiratory Syncytial Virus Diagnostics market size is projected to reach US$ 599.3 million by 2026, from US$ 564.4 million in 2020, at a CAGR of 5.7%% during 2021-2026.
Global Respiratory Syncytial Virus Diagnostics Scope and Market Size
Respiratory Syncytial Virus Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Respiratory Syncytial Virus Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Becton Dickinson
Abbott Laboratories
Abbott
Beckman Coulter/Danaher
Bio-Rad Laboratories
Coris BioConcept
DiaSorin SPA
Eiken Chemical
Elitech
Fujirebio
Grifols
Hoffmann La Roche
Hologic
Novartis Diagnostics
Ortho Clinical Diagnostics
Roche Diagnostics
Scienion
Respiratory Syncytial Virus Diagnostics Breakdown Data by Type
Direct Fluorescent Antibody Method
Rapid Antigen Diagnostic Tests
Molecular Diagnostics
Chromatographic Immunoassay
Diagnostic Imaging
Gel Microdroplets
Flow Cytometry
Other
Respiratory Syncytial Virus Diagnostics Breakdown Data by Application
Hospitals
Laboratory
Clinics
Homecare
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Respiratory Syncytial Virus Diagnostics Revenue
1.4 Market by Type
1.4.1 Global Respiratory Syncytial Virus Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Direct Fluorescent Antibody Method
1.4.3 Rapid Antigen Diagnostic Tests
1.4.4 Molecular Diagnostics
1.4.5 Chromatographic Immunoassay
1.4.6 Diagnostic Imaging
1.4.7 Gel Microdroplets
1.4.8 Flow Cytometry
1.4.9 Other
1.5 Market by Application
1.5.1 Global Respiratory Syncytial Virus Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Laboratory
1.5.4 Clinics
1.5.5 Homecare
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Syncytial Virus Diagnostics Market Perspective (2015-2026)
2.2 Global Respiratory Syncytial Virus Diagnostics Growth Trends by Regions
2.2.1 Respiratory Syncytial Virus Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Respiratory Syncytial Virus Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Respiratory Syncytial Virus Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Respiratory Syncytial Virus Diagnostics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Syncytial Virus Diagnostics Players by Market Size
3.1.1 Global Top Respiratory Syncytial Virus Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Respiratory Syncytial Virus Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Respiratory Syncytial Virus Diagnostics Market Concentration Ratio
3.2.1 Global Respiratory Syncytial Virus Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Respiratory Syncytial Virus Diagnostics Revenue in 2019
3.3 Respiratory Syncytial Virus Diagnostics Key Players Head office and Area Served
3.4 Key Players Respiratory Syncytial Virus Diagnostics Product Solution and Service
3.5 Date of Enter into Respiratory Syncytial Virus Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Respiratory Syncytial Virus Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020)
5.2 Global Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Respiratory Syncytial Virus Diagnostics Market Size (2015-2020)
6.2 Respiratory Syncytial Virus Diagnostics Key Players in North America (2019-2020)
6.3 North America Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020)
6.4 North America Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Respiratory Syncytial Virus Diagnostics Market Size (2015-2020)
7.2 Respiratory Syncytial Virus Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020)
7.4 Europe Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020)
8 China
8.1 China Respiratory Syncytial Virus Diagnostics Market Size (2015-2020)
8.2 Respiratory Syncytial Virus Diagnostics Key Players in China (2019-2020)
8.3 China Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020)
8.4 China Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Respiratory Syncytial Virus Diagnostics Market Size (2015-2020)
9.2 Respiratory Syncytial Virus Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020)
9.4 Japan Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Respiratory Syncytial Virus Diagnostics Market Size (2015-2020)
10.2 Respiratory Syncytial Virus Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020)
11 India
11.1 India Respiratory Syncytial Virus Diagnostics Market Size (2015-2020)
11.2 Respiratory Syncytial Virus Diagnostics Key Players in India (2019-2020)
11.3 India Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020)
11.4 India Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Respiratory Syncytial Virus Diagnostics Market Size (2015-2020)
12.2 Respiratory Syncytial Virus Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Becton Dickinson
13.1.1 Becton Dickinson Company Details
13.1.2 Becton Dickinson Business Overview
13.1.3 Becton Dickinson Respiratory Syncytial Virus Diagnostics Introduction
13.1.4 Becton Dickinson Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020))
13.1.5 Becton Dickinson Recent Development
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Details
13.2.2 Abbott Laboratories Business Overview
13.2.3 Abbott Laboratories Respiratory Syncytial Virus Diagnostics Introduction
13.2.4 Abbott Laboratories Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.2.5 Abbott Laboratories Recent Development
13.3 Abbott
13.3.1 Abbott Company Details
13.3.2 Abbott Business Overview
13.3.3 Abbott Respiratory Syncytial Virus Diagnostics Introduction
13.3.4 Abbott Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.3.5 Abbott Recent Development
13.4 Beckman Coulter/Danaher
13.4.1 Beckman Coulter/Danaher Company Details
13.4.2 Beckman Coulter/Danaher Business Overview
13.4.3 Beckman Coulter/Danaher Respiratory Syncytial Virus Diagnostics Introduction
13.4.4 Beckman Coulter/Danaher Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.4.5 Beckman Coulter/Danaher Recent Development
13.5 Bio-Rad Laboratories
13.5.1 Bio-Rad Laboratories Company Details
13.5.2 Bio-Rad Laboratories Business Overview
13.5.3 Bio-Rad Laboratories Respiratory Syncytial Virus Diagnostics Introduction
13.5.4 Bio-Rad Laboratories Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.5.5 Bio-Rad Laboratories Recent Development
13.6 Coris BioConcept
13.6.1 Coris BioConcept Company Details
13.6.2 Coris BioConcept Business Overview
13.6.3 Coris BioConcept Respiratory Syncytial Virus Diagnostics Introduction
13.6.4 Coris BioConcept Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.6.5 Coris BioConcept Recent Development
13.7 DiaSorin SPA
13.7.1 DiaSorin SPA Company Details
13.7.2 DiaSorin SPA Business Overview
13.7.3 DiaSorin SPA Respiratory Syncytial Virus Diagnostics Introduction
13.7.4 DiaSorin SPA Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.7.5 DiaSorin SPA Recent Development
13.8 Eiken Chemical
13.8.1 Eiken Chemical Company Details
13.8.2 Eiken Chemical Business Overview
13.8.3 Eiken Chemical Respiratory Syncytial Virus Diagnostics Introduction
13.8.4 Eiken Chemical Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.8.5 Eiken Chemical Recent Development
13.9 Elitech
13.9.1 Elitech Company Details
13.9.2 Elitech Business Overview
13.9.3 Elitech Respiratory Syncytial Virus Diagnostics Introduction
13.9.4 Elitech Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.9.5 Elitech Recent Development
13.10 Fujirebio
13.10.1 Fujirebio Company Details
13.10.2 Fujirebio Business Overview
13.10.3 Fujirebio Respiratory Syncytial Virus Diagnostics Introduction
13.10.4 Fujirebio Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.10.5 Fujirebio Recent Development
13.11 Grifols
10.11.1 Grifols Company Details
10.11.2 Grifols Business Overview
10.11.3 Grifols Respiratory Syncytial Virus Diagnostics Introduction
10.11.4 Grifols Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
10.11.5 Grifols Recent Development
13.12 Hoffmann La Roche
10.12.1 Hoffmann La Roche Company Details
10.12.2 Hoffmann La Roche Business Overview
10.12.3 Hoffmann La Roche Respiratory Syncytial Virus Diagnostics Introduction
10.12.4 Hoffmann La Roche Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
10.12.5 Hoffmann La Roche Recent Development
13.13 Hologic
10.13.1 Hologic Company Details
10.13.2 Hologic Business Overview
10.13.3 Hologic Respiratory Syncytial Virus Diagnostics Introduction
10.13.4 Hologic Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
10.13.5 Hologic Recent Development
13.14 Novartis Diagnostics
10.14.1 Novartis Diagnostics Company Details
10.14.2 Novartis Diagnostics Business Overview
10.14.3 Novartis Diagnostics Respiratory Syncytial Virus Diagnostics Introduction
10.14.4 Novartis Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
10.14.5 Novartis Diagnostics Recent Development
13.15 Ortho Clinical Diagnostics
10.15.1 Ortho Clinical Diagnostics Company Details
10.15.2 Ortho Clinical Diagnostics Business Overview
10.15.3 Ortho Clinical Diagnostics Respiratory Syncytial Virus Diagnostics Introduction
10.15.4 Ortho Clinical Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
10.15.5 Ortho Clinical Diagnostics Recent Development
13.16 Roche Diagnostics
10.16.1 Roche Diagnostics Company Details
10.16.2 Roche Diagnostics Business Overview
10.16.3 Roche Diagnostics Respiratory Syncytial Virus Diagnostics Introduction
10.16.4 Roche Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
10.16.5 Roche Diagnostics Recent Development
13.17 Scienion
10.17.1 Scienion Company Details
10.17.2 Scienion Business Overview
10.17.3 Scienion Respiratory Syncytial Virus Diagnostics Introduction
10.17.4 Scienion Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
10.17.5 Scienion Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Respiratory Syncytial Virus Diagnostics Revenue
1.4 Market by Type
1.4.1 Global Respiratory Syncytial Virus Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Direct Fluorescent Antibody Method
1.4.3 Rapid Antigen Diagnostic Tests
1.4.4 Molecular Diagnostics
1.4.5 Chromatographic Immunoassay
1.4.6 Diagnostic Imaging
1.4.7 Gel Microdroplets
1.4.8 Flow Cytometry
1.4.9 Other
1.5 Market by Application
1.5.1 Global Respiratory Syncytial Virus Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Laboratory
1.5.4 Clinics
1.5.5 Homecare
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Syncytial Virus Diagnostics Market Perspective (2015-2026)
2.2 Global Respiratory Syncytial Virus Diagnostics Growth Trends by Regions
2.2.1 Respiratory Syncytial Virus Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Respiratory Syncytial Virus Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Respiratory Syncytial Virus Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Respiratory Syncytial Virus Diagnostics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Syncytial Virus Diagnostics Players by Market Size
3.1.1 Global Top Respiratory Syncytial Virus Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Respiratory Syncytial Virus Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Respiratory Syncytial Virus Diagnostics Market Concentration Ratio
3.2.1 Global Respiratory Syncytial Virus Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Respiratory Syncytial Virus Diagnostics Revenue in 2019
3.3 Respiratory Syncytial Virus Diagnostics Key Players Head office and Area Served
3.4 Key Players Respiratory Syncytial Virus Diagnostics Product Solution and Service
3.5 Date of Enter into Respiratory Syncytial Virus Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Respiratory Syncytial Virus Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020)
5.2 Global Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Respiratory Syncytial Virus Diagnostics Market Size (2015-2020)
6.2 Respiratory Syncytial Virus Diagnostics Key Players in North America (2019-2020)
6.3 North America Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020)
6.4 North America Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Respiratory Syncytial Virus Diagnostics Market Size (2015-2020)
7.2 Respiratory Syncytial Virus Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020)
7.4 Europe Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020)
8 China
8.1 China Respiratory Syncytial Virus Diagnostics Market Size (2015-2020)
8.2 Respiratory Syncytial Virus Diagnostics Key Players in China (2019-2020)
8.3 China Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020)
8.4 China Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Respiratory Syncytial Virus Diagnostics Market Size (2015-2020)
9.2 Respiratory Syncytial Virus Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020)
9.4 Japan Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Respiratory Syncytial Virus Diagnostics Market Size (2015-2020)
10.2 Respiratory Syncytial Virus Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020)
11 India
11.1 India Respiratory Syncytial Virus Diagnostics Market Size (2015-2020)
11.2 Respiratory Syncytial Virus Diagnostics Key Players in India (2019-2020)
11.3 India Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020)
11.4 India Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Respiratory Syncytial Virus Diagnostics Market Size (2015-2020)
12.2 Respiratory Syncytial Virus Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Becton Dickinson
13.1.1 Becton Dickinson Company Details
13.1.2 Becton Dickinson Business Overview
13.1.3 Becton Dickinson Respiratory Syncytial Virus Diagnostics Introduction
13.1.4 Becton Dickinson Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020))
13.1.5 Becton Dickinson Recent Development
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Details
13.2.2 Abbott Laboratories Business Overview
13.2.3 Abbott Laboratories Respiratory Syncytial Virus Diagnostics Introduction
13.2.4 Abbott Laboratories Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.2.5 Abbott Laboratories Recent Development
13.3 Abbott
13.3.1 Abbott Company Details
13.3.2 Abbott Business Overview
13.3.3 Abbott Respiratory Syncytial Virus Diagnostics Introduction
13.3.4 Abbott Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.3.5 Abbott Recent Development
13.4 Beckman Coulter/Danaher
13.4.1 Beckman Coulter/Danaher Company Details
13.4.2 Beckman Coulter/Danaher Business Overview
13.4.3 Beckman Coulter/Danaher Respiratory Syncytial Virus Diagnostics Introduction
13.4.4 Beckman Coulter/Danaher Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.4.5 Beckman Coulter/Danaher Recent Development
13.5 Bio-Rad Laboratories
13.5.1 Bio-Rad Laboratories Company Details
13.5.2 Bio-Rad Laboratories Business Overview
13.5.3 Bio-Rad Laboratories Respiratory Syncytial Virus Diagnostics Introduction
13.5.4 Bio-Rad Laboratories Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.5.5 Bio-Rad Laboratories Recent Development
13.6 Coris BioConcept
13.6.1 Coris BioConcept Company Details
13.6.2 Coris BioConcept Business Overview
13.6.3 Coris BioConcept Respiratory Syncytial Virus Diagnostics Introduction
13.6.4 Coris BioConcept Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.6.5 Coris BioConcept Recent Development
13.7 DiaSorin SPA
13.7.1 DiaSorin SPA Company Details
13.7.2 DiaSorin SPA Business Overview
13.7.3 DiaSorin SPA Respiratory Syncytial Virus Diagnostics Introduction
13.7.4 DiaSorin SPA Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.7.5 DiaSorin SPA Recent Development
13.8 Eiken Chemical
13.8.1 Eiken Chemical Company Details
13.8.2 Eiken Chemical Business Overview
13.8.3 Eiken Chemical Respiratory Syncytial Virus Diagnostics Introduction
13.8.4 Eiken Chemical Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.8.5 Eiken Chemical Recent Development
13.9 Elitech
13.9.1 Elitech Company Details
13.9.2 Elitech Business Overview
13.9.3 Elitech Respiratory Syncytial Virus Diagnostics Introduction
13.9.4 Elitech Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.9.5 Elitech Recent Development
13.10 Fujirebio
13.10.1 Fujirebio Company Details
13.10.2 Fujirebio Business Overview
13.10.3 Fujirebio Respiratory Syncytial Virus Diagnostics Introduction
13.10.4 Fujirebio Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.10.5 Fujirebio Recent Development
13.11 Grifols
10.11.1 Grifols Company Details
10.11.2 Grifols Business Overview
10.11.3 Grifols Respiratory Syncytial Virus Diagnostics Introduction
10.11.4 Grifols Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
10.11.5 Grifols Recent Development
13.12 Hoffmann La Roche
10.12.1 Hoffmann La Roche Company Details
10.12.2 Hoffmann La Roche Business Overview
10.12.3 Hoffmann La Roche Respiratory Syncytial Virus Diagnostics Introduction
10.12.4 Hoffmann La Roche Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
10.12.5 Hoffmann La Roche Recent Development
13.13 Hologic
10.13.1 Hologic Company Details
10.13.2 Hologic Business Overview
10.13.3 Hologic Respiratory Syncytial Virus Diagnostics Introduction
10.13.4 Hologic Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
10.13.5 Hologic Recent Development
13.14 Novartis Diagnostics
10.14.1 Novartis Diagnostics Company Details
10.14.2 Novartis Diagnostics Business Overview
10.14.3 Novartis Diagnostics Respiratory Syncytial Virus Diagnostics Introduction
10.14.4 Novartis Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
10.14.5 Novartis Diagnostics Recent Development
13.15 Ortho Clinical Diagnostics
10.15.1 Ortho Clinical Diagnostics Company Details
10.15.2 Ortho Clinical Diagnostics Business Overview
10.15.3 Ortho Clinical Diagnostics Respiratory Syncytial Virus Diagnostics Introduction
10.15.4 Ortho Clinical Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
10.15.5 Ortho Clinical Diagnostics Recent Development
13.16 Roche Diagnostics
10.16.1 Roche Diagnostics Company Details
10.16.2 Roche Diagnostics Business Overview
10.16.3 Roche Diagnostics Respiratory Syncytial Virus Diagnostics Introduction
10.16.4 Roche Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
10.16.5 Roche Diagnostics Recent Development
13.17 Scienion
10.17.1 Scienion Company Details
10.17.2 Scienion Business Overview
10.17.3 Scienion Respiratory Syncytial Virus Diagnostics Introduction
10.17.4 Scienion Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
10.17.5 Scienion Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
